Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Dr. Lal Pathlabs (DLPA.BO)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rs)	Price Target (Rs)	Rating
2022-02-16	2713.45	3900.00	Buy
2022-03-16	2699.00	3700.00	Buy
2022-07-25	2101.10	2800.00	Buy
2022-07-28	2142.80	2700.00	Buy
2022-09-16	2298.65	2800.00	Buy
2023-02-06	1967.55	2600.00	Buy
2023-05-11	1906.80	2500.00	Buy
2023-09-18	2360.35	2800.00	Buy
2023-11-03	2593.40	2950.00	Buy
2024-03-21	2079.40	2900.00	Buy
2024-07-09	2924.00	3500.00	Buy
2024-11-08	3058.80	-	No Rating
2024-11-13	2964.25	3500.00	Buy
2025-01-30	2879.40	3350.00	Buy
2025-04-04	2514.60	3330.00	Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.